Chison Medical Technologies, in response to the Shanghai Stock Exchange's annual report inquiry letter, stated that its net profit in the fourth quarter of 2025 fell sharply by 46.36% year-on-year, with the core reason being a significant year-on-year shrinkage in exchange gains caused by major fluctuations in the US dollar exchange rate during the period. The company incurred an exchange loss of 5.95 million yuan for the full year. After excluding the impact of exchange gains and losses, the decline in net profit was broadly in line with the decline in revenue. Full-year revenue for 2025 decreased by 7.02% year-on-year, mainly because US tariff hikes led local customers to scale back purchases of portable color ultrasound devices, coupled with domestic centralized procurement extending procurement cycles. Fourth-quarter revenue fell 12.97% year-on-year, primarily due to the delivery of some orders being postponed to the first quarter of 2026 for recognition. The company stated that first-quarter 2026 revenue reached 127 million yuan, roughly flat year-on-year, while net profit grew by 10.60%, indicating that operations are showing signs of bottoming out and stabilizing. It is also advancing AI product upgrades and a global localization layout to improve performance.
Chison Medical Technologies Co LtdQ4 2025 net profit plunged 46.36% YoY due to exchange losses and revenue decline.